BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 9, 2026
Breaking News: BioWorld Science 2025 Year in Review
Breaking News: BioWorld 2025 Year in Review
Breaking News: BioWorld MedTech 2025 Year in Review
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Lamotrigine, valproate tested in mood disorders
Aug. 16, 1996
Meiji Seika claims bicyclic thiazoles for CNS disorders
Aug. 16, 1996
Allelix describes D4 antagonists for schizophrenia
Aug. 16, 1996
BTS-73947: new D1/D5 antagonist from Knoll
Aug. 16, 1996
Roche profiles pharmacokinetics, pharmacodynamics of new benzodiazepine
Aug. 16, 1996
first clinical study results reported for Ro-48-6791
Aug. 16, 1996
LY-23728, 5-HT2B antagonist reported by Lilly
Aug. 16, 1996
5-HT2 receptor ligands reported by Allelix
Aug. 16, 1996
Histamine H3 agonist increases slow-wave sleep in rats
Aug. 16, 1996
VML-251 phase IIa results reported
Aug. 16, 1996
Previous
1
2
…
2747
2748
2749
2750
2751
2752
2753
2754
2755
…
2781
2782
Next